Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 25.35
-0.83 (-3.17%)
Sep 24, 2026, 3:00 PM CST
SHA:688321 Market Cap
SHA:688321 has a market cap or net worth of 11.21 billion as of September 25, 2026. Its market cap has decreased by -14.58% in one year.
Market Cap
11.21B
Enterprise Value
11.18B
Revenue
1.05B
Ranking
n/a
PE Ratio
115.02
Stock Price
25.35
ChartMarket Cap Chart
Since August 12, 2019, SHA:688321's market cap has decreased from 39.08B to 11.21B, a decrease of -71.30%. That is a compound annual growth rate of -16.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 11.21B | -5.90% |
| Dec 31, 2025 | 11.92B | 57.27% |
| Dec 31, 2024 | 7.58B | -15.30% |
| Dec 29, 2023 | 8.95B | - |
| Dec 30, 2022 | 8.95B | -37.79% |
| Dec 31, 2021 | 14.38B | -5.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 12.69B |
| PharmaBlock Sciences (Nanjing) | 12.66B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.43B |
| Beijing Aosaikang Pharmaceutical | 12.04B |
| Zhejiang Medicine | 11.69B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.64B |
| Guangdong Taienkang Pharmaceutical | 11.07B |
| Wedge Industrial | 11.06B |